Molecular engineering on Primary–Auxiliary Ligand Co-regulation
- 1College of Chemistry, Jilin University, Liutiao Road #2, Changchun, 130061
- 2School of Physics
- 3Northeast Normal University
Abstract
Two-photon photodynamic therapy (TP-PDT) is a clinically valuable cancer treatment modality owing to its deep tissue penetration, high spatial selectivity, and minimal damage to normal tissues. Here, Ir(III) complex photosensitizers for PDT were designed and investigated through cooperative C^N/N^N dual-ligand modification of [Ir(ppy)2(osip)] (PF6) (Ir-1). The origin of the performance loss arising from combining two individually optimized ligands was elucidated using DFT/TD-DFT calculations. The N^N ligand provides the charge-transfer framework governing triplet energy and the dominant two-photon absorption (TPA) channel, while C^N substituents fine-tune electron–hole separation, rigidity, and excited-state relaxation within this framework. When combined with an electron-withdrawing N^N ligand, electron-donating substitution on the C^N ligand red-shifts the TPA maximum of Ir-a3 to 668.4 nm, within the biological window, and extends its triplet lifetime to 2995.06 μs. In contrast, strong electron-withdrawing substituents on the C^N ligand deactivate intersystem crossing and consequently suppress PDT activity. All T1-accessible complexes also meet the thermodynamic requirements for Type I and Type II photosensitization, with LogP values of 1.59–2.51. Owing to its longest triplet lifetime, TPA maximum within the biological window and balanced solubility (ΔGsolv = -47.93 kcal/mol) and lipophilicity (LogP = 2.12), Ir-a3 is expected to be a promising PDT candidate. The cooperative, rather than simply additive, nature of the dual-ligand effect is explicitly demonstrated for the first time. These findings establish a strategy for the cooperative modification of primary and auxiliary ligands in Ir(III) complex photosensitizers.
Related
- Exploring the potential role of PD-L2 in primary melanoma immunotherapy resistance: a hypothesis-driven dual-ligand framework
- Increased Interleukin-17C Production by the Toll-Like Receptor 3 Ligand Poly(I:C) in Primary Cystic Fibrosis Airway Epithelial Cells
- Novel Copper (II) Complex Derived from Sulfadiazine Azo Resorcinol Ligand: Characterization, Antibacterial Evaluation, and Molecular Docking Study.
- Differential Regulation of Cholesterol-Related Gene Expression by HDAC Inhibition in Neuron-Enriched and Glia-Enriched Rat Primary Cultures
- Students' aerobic fitness, self-regulation, and mathematical performance in primary school.
BibTeX
@misc{zhang2026molecular,
title = {{Molecular engineering on Primary–Auxiliary Ligand Co-regulation}},
author = {Yu-dan Zhang and Feng-yi Sun and Jia-ying Zhao and Matyusup Aynur and Lu-yi Zou and Ai-min Ren and Jing-fu Guo},
howpublished = {ChemRxiv},
year = {2026},
month = oct,
doi = {10.26434/chemrxiv.15011115/v1},
url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15011115/v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Molecular engineering on Primary–Auxiliary Ligand Co-regulation
AU - Yu-dan Zhang
AU - Feng-yi Sun
AU - Jia-ying Zhao
AU - Matyusup Aynur
AU - Lu-yi Zou
AU - Ai-min Ren
AU - Jing-fu Guo
PY - 2026
DA - 2026/10/27
PB - ChemRxiv
DO - 10.26434/chemrxiv.15011115/v1
UR - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15011115/v1
AB - Two-photon photodynamic therapy (TP-PDT) is a clinically valuable cancer treatment modality owing to its deep tissue penetration, high spatial selectivity, and minimal damage to normal tissues. Here, Ir(III) complex photosensitizers for PDT were designed and investigated through cooperative C^N/N^N dual-ligand modification of [Ir(ppy)2(osip)] (PF6) (Ir-1). The origin of the performance loss arising from combining two individually optimized ligands was elucidated using DFT/TD-DFT calculations. The N^N ligand provides the charge-transfer framework governing triplet energy and the dominant two-photon absorption (TPA) channel, while C^N substituents fine-tune electron–hole separation, rigidity, and excited-state relaxation within this framework. When combined with an electron-withdrawing N^N ligand, electron-donating substitution on the C^N ligand red-shifts the TPA maximum of Ir-a3 to 668.4 nm, within the biological window, and extends its triplet lifetime to 2995.06 μs. In contrast, strong electron-withdrawing substituents on the C^N ligand deactivate intersystem crossing and consequently suppress PDT activity. All T1-accessible complexes also meet the thermodynamic requirements for Type I and Type II photosensitization, with LogP values of 1.59–2.51. Owing to its longest triplet lifetime, TPA maximum within the biological window and balanced solubility (ΔGsolv = -47.93 kcal/mol) and lipophilicity (LogP = 2.12), Ir-a3 is expected to be a promising PDT candidate. The cooperative, rather than simply additive, nature of the dual-ligand effect is explicitly demonstrated for the first time. These findings establish a strategy for the cooperative modification of primary and auxiliary ligands in Ir(III) complex photosensitizers.
ER -